A precision approach to tumour treatment

Nature

Volumn 548, Issue 7665, 2017, Pages 40-41

  Dienstmann, Rodrigo ^a,b   Tabernero, Josep ^c  

^a VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^b SAGE BIONETWORKS   (United States)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; CANCER; CELLS AND CELL COMPONENTS; DNA; DRUG; GENE EXPRESSION; GENETIC ANALYSIS; NUMERICAL MODEL; PRECISION; PROTEIN; TUMOR;

CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER THERAPY; CYTOPLASM; DECISION MAKING; DNA SEQUENCE; DRUG EFFICACY; DRUG SENSITIVITY; GENE EXPRESSION; GENOME; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; METASTASIS; MONOLAYER CULTURE; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SHORT SURVEY; STROMA CELL; TREATMENT RESPONSE; TUMOR CELL; TUMOR MODEL; NEOPLASM;

HUMANS; NEOPLASMS; PRECISION MEDICINE;

EID: 85026830370     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature23101     Document Type: Short Survey

References (7)

1. Pauli, C. et al. Cancer Discov. 7, 462-477 (2017).
2. Massard, C. et al. Cancer Discov. 7, 586-595 (2017).
3. Pemovska, T. et al. Cancer Discov. 3, 1416-1429 (2013).
4. Schütte, M. et al. Nature Commun. 8, 14262 (2017).
5. van de Wetering, M. et al. Cell 161, 933-945 (2015).
6. Crespo, M. et al. Nature Med. 23, 878-884 (2017).
7. https://www.clinicaltrials.gov/ct2/show/ NCT01351103